全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... François Guilhot , Marco Vignetti , Fabio Efficace
来源:[J].Health and Quality of Life Outcomes(IF 2.272), 2017, Vol.15 (1)Springer
摘要:We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML).
作者:Fabio Efficace , Sophie D. Fosså ...
来源:[J].Health and Quality of Life Outcomes(IF 2.272), 2017, Vol.15 (1)Springer
摘要:Understanding of the physical, functional and psychosocial health problems and needs of cancer survivors requires cross-national and cross-cultural standardization of health-related quality of life (HRQoL) questionnaires that capture the full range of issues relevant to cancer su...
作者:... Antonio Cozzio , Fabio Efficace , Julia Scarisbrick
来源:[J].Acta Dermato-Venereologica(IF 3.487), 2019, Vol.99 (7), pp.640-646DOAJ
摘要:Previous studies have reported that primary cutaneous lymphomas profoundly influence patients’ health-related quality of life (HRQoL). However, assessment of this psycho-social concept is not common in routine patient care unless required within clinical trials. The aim of t...
作者:Fabio Efficace , Mario Boccadoro ...
来源:[J].Health and Quality of Life Outcomes(IF 2.272), 2018, Vol.16 (1), pp.1-9DOAJ
摘要:Abstract Background Treatment decision-making in patients with relapsed/refractory multiple myeloma (RRMM) is challenging for a number of reasons including, the heterogeneity of disease at relapse and the number of possible therapeutic approaches. This study broadly aims to ...
作者:... Marco Vignetti , Franco Mandelli , Fabio Efficace
来源:[J].Critical Reviews in Oncology / Hematology(IF 4.637), 2015, Vol.96 (3), pp.542-554Elsevier
摘要:Abstract(#br)Health-related quality of life (HRQOL) and other patient-reported outcomes (PROs) are crucial for a comprehensive evaluation of treatment effectiveness. A systematic review of randomized controlled trials (RCTs) with a PRO endpoint conducted in patients with leukemia...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×